Nikhil Prasad Fact checked by:Thailand Medical News Team Oct 28, 2024 1 month, 2 weeks, 17 hours, 57 minutes ago
Medical News: A new study from researchers in Korea explored the potential for eye-related health risks following COVID-19 infection. Researchers from institutions including Samsung Medical Center, Sungkyunkwan University, and Kyung Hee University analyzed data to understand if COVID-19 raised risks for ocular issues such as retinal artery occlusion (RAO), retinal vein occlusion (RVO), optic neuritis, and other inflammatory eye diseases. This
Medical News report reviews the study’s key findings, which highlighted a specific risk increase for people with heart disease.
COVID-19 Linked to Certain Eye Risks in Patients with Heart Disease
The Scope of the Study
The research, conducted as a population-wide, self-controlled case series study, covered the entire Korean population between January 2021 and October 2022. Researchers focused on eight types of eye issues: RAO, RVO, non-infectious uveitis (NIU), non-infectious scleritis (NIS), optic neuritis (ON), ischemic optic neuropathy (ION), and ocular motor cranial nerve palsy (OMCNP). Data from the Korean National Health Insurance Service and Korea Disease Control and Prevention Agency were used to track patients who developed these eye conditions after COVID-19 infection, a methodology that helps improve the reliability of the results by using each individual as their control.
COVID-19’s Effect on Eye Health: Findings and Implications
One key takeaway was that COVID-19 did not generally increase the risk of most eye conditions, with one notable exception. For people with a history of cardio-cerebrovascular disease - such as heart disease or stroke - the study found an increased risk of retinal artery occlusion in the later stages after a COVID-19 infection. RAO, a condition where blood flow is blocked in the retina’s arteries, was significantly more common among those with pre-existing heart conditions.
What the Findings Reveal
To evaluate the risk changes, the study calculated incidence rate ratios (IRRs) for each eye condition during risk periods after COVID-19 infection. This means comparing each patient’s rate of developing these conditions before and after COVID-19. Overall, the analysis found no elevated risk of eye diseases like RVO, NIU, NIS, or ION for the general population post-infection. But in the late period, roughly nine to 24 weeks after infection, the risk of RAO notably rose in people with a history of cardiovascular disease.
Mechanisms of COVID-19’s Impact on Eye Health
The researchers suggested that COVID-19’s inflammatory effects could explain the elevated risk of RAO in patients with cardiovascular disease. COVID-19 triggers the release of inflammatory molecules like IL-6 and TNF-α, which can damage blood vessel walls and encourage blood clotting. For individuals with pre-existing heart or vascular issues, these inflammatory responses may heighten the risk of vascular blockages, potentially affecting blood flow to the retina and causing RAO. Researchers extended the study&am
p;rsquo;s analysis period to 24 weeks after COVID-19 infection to capture potential long-term effects on the body’s immune system.
Findings from Previous Studies
Prior studies on COVID-19 and eye health have yielded mixed results. While some studies, like those conducted in the U.S., identified an increased risk of retinal vascular occlusions post-infection, others found no significant rise in such conditions. For instance, a Korean study comparing the rates of RAO and RVO between infected and non-infected groups found no difference. In contrast, research conducted in the U.S. reported an elevated risk of RVO but not RAO following COVID-19.
Limitations of the Study
While the study’s design controls for individual differences by using a self-controlled case series, certain limitations remain. Diagnoses were based on insurance codes rather than clinical exams, which means certain details might not be fully captured. Additionally, while the study covered a large number of COVID-19 cases, it focused only on data through October 2022. Consequently, the long-term effects of COVID-19 on eye health beyond six months remain unknown.
Future research could help to determine if these findings apply to populations outside Korea and provide further insights into possible long-term impacts.
Conclusions and Implications for Patients
In summary, the study suggests that COVID-19 generally does not increase the risk of eye-related health issues, except for RAO in people with cardiovascular disease. The findings underscore the importance of close monitoring for individuals with heart or vascular conditions post-COVID-19. Healthcare providers might consider additional precautions or follow-up for these patients, especially in the months following infection. With COVID-19 continuing to circulate, understanding its broader health impacts remains crucial for better patient care.
The study findings were published in the peer-reviewed journal: Ophthalmology Science.
https://www.sciencedirect.com/science/article/pii/S266691452400174X
For the latest COVID-19 News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/mild-covid-19-can-cause-eye-artery-blockages
https://www.thailandmedical.news/news/insights-from-a-brazilian-study-on-prolonged-monkeypox-mpox-virus-shedding-in-the-eyes
https://www.thailandmedical.news/news/breaking-brazilian-study-reveals-potential-impact-of-covid-19-on-babies-vision
Share
Tweet
Share
